Riskpilot← Back to searchSign inGet full accessHälsoprodukter i Bollnäs AB
ABActiveOrg 5565611836Nygatan 21Retail sale of other food · NACE 4727Est. 19981-4 employees
Revenue 2025
SEK 7,2M
-28% vs 2024
EBITDA margin
0.2%
+107% vs 2024
Equity ratio
29.2%
Financial strength
Net profit 2025
SEK -12K
+93% vs 2024
| Revenue | SEK 7,2M | -28% |
| EBITDA | SEK 13K | +107% |
| Net profit | SEK -12K | +93% |
| Total assets | SEK 2M | -8% |
| Equity | SEK 591K | -26% |
| Employees | — | — |
Legal name
Hälsoprodukter i Bollnäs AB
Org number
5565611836
Legal form
Aktiebolag
NACE code
4727 · Retail sale of other food
Founded
27 oktober 1998
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva försäljning av naturmedel, naturläkemedel, mat och hudvård samt därmed förenlig verksamhet.
Address
Nygatan 21
Email
sylvia@halsokraft.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 11 315 | 11 564 | 10 327 | 9 987 | 7 195 |
| Staff expenses | — | — | — | −2 835 | −1 936 |
| EBITDA | 178 | 377 | −166 | −194 | 13 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 178 | 377 | −166 | −194 | 13 |
| Net financials | 75 | −22 | 127 | 39 | −25 |
| Profit before tax | 253 | 355 | 94 | −155 | −12 |
| Tax | −36 | −74 | −0 | — | — |
| Net profit | 217 | 281 | 94 | −155 | −12 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 396 | 2 907 | 2 863 | 2 208 | 2 025 |
| Equity | 1 033 | 1 114 | 1 107 | 803 | 591 |
| Long-term debt | 234 | 323 | 357 | 365 | 379 |
| Short-term debt | 997 | 1 338 | 1 398 | 1 041 | 1 054 |
| Total debt | 1 231 | 1 661 | 1 755 | 1 406 | 1 433 |
EBITDA margin
0.2%
This company
15.8%
Market median
-99% vs market
20212025
Equity ratio
29.2%
This company
38.2%
Market median
-24% vs market
20212025
Return on equity
-2.0%
This company
18.4%
Market median
-111% vs market
20212025
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20212025
Asset turnover
3.55×
This company
1.12×
Market median
+217% vs market
20212025
Debt / equity
2.42×
This company
0.62×
Market median
-290% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM Audit | Audit | 2022 |
| Former (2) | ||
SK Chief Auditor | Chief Auditor | 2021 – 2022 |
ER Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsoprodukter i Bollnäs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Kristina Persson | Chief Auditor | 0 companies |
| Jan Magnus Rosén | Audit | 0 companies |
| Ernst Ragnar Jon Pettersson | Chief Auditor | 0 companies |
| Max Eriksson | Deputy Board Member | 0 companies |
| Per Helge Jonsson | Deputy Board Member | 0 companies |
| Sylvia Elisabeth Nord | Board of Directors | 0 companies |